World Vaping Alliance Criticizes EU Report on E-Cigarettes

May.13.2022
World Vaping Alliance Criticizes EU Report on E-Cigarettes
The WVA criticizes EU SCHEER's report on e-cigarettes for ignoring scientific evidence and consumer success stories, causing negative consequences.

A press release from the World Vapers' Alliance (WVA) has emphasized that a recent report from the European Union's Health, Environment and New Risks Scientific Committee (SCHEER) on e-cigarettes is a setback for public health in Europe. This is because the report ignores all scientific evidence that shows e-cigarettes can reduce the harm caused by tobacco, as well as ignoring successful cases of smokers quitting and expert opinions received during the consultation period.

 

Michael Landl, Director of the World Vapers' Alliance (WVA), commented on the report, stating that the misinformation presented will have negative consequences: “This report is a tragedy for public health and will have terrible consequences for smokers and vapers. SCHEER has ignored a wealth of scientific evidence on e-cigarettes, all of which was provided by experts and consumers during consultations earlier this year. They have chosen to ignore it, showing disregard for vapers and common sense.”

 

Patterns of Inaccurate Reporting in the Scheer Report

 

Earlier this year, a renowned expert on reducing the harm caused by tobacco, Dr. Riccardo Polosa, published a paper stating that SCHEER's conclusions lacked sufficient scientific evidence and did not address the health benefits of using electronic cigarettes as a substitute for traditional cigarettes.

 

The SCHEER report on cardiovascular risk assessment contradicts many studies and references data that does not represent current usage patterns. It does not include a report on non-nicotine use. The report makes inaccurate statements about the trend of e-cigarette use and places too much emphasis on the role of flavors in youth initiation without sufficient long-term data.

 

Dr. Riccardo Polosa added that the report did not take into account well-known UK public health data that show e-cigarettes are 95% less harmful than smoking and have recently become the most commonly used tool for quitting smoking.

 

Countries such as the UK and France are actively encouraging smokers to switch to e-cigarettes, a less harmful alternative. If the EU genuinely wants to address smoking-related illnesses, it needs to carefully examine all the evidence. Unfortunately, the SCHEER report is biased against e-cigarettes, and if its recommendations were translated into legislation, it would harm public health.

 

Recommendations on accurate reporting

 

In order to provide accurate reporting, Dr. Riccardo Polosa and his team have drafted some recommendations for SCHEER.

 

(1) The potential health benefits of electronic cigarettes as a replacement for traditional cigarettes.

 

Research on the behavior of switching and substitution between the two.

 

(3) Assessment of cardiovascular risk.

 

Measurement of frequency of use.

 

Non-nicotine usage.

 

The Function of Spices.

 

Conduct thorough research on the effectiveness of quitting smoking.

 

Source: VapingPost

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Australia TGA Warns Delivery Platforms: Don’t Promote or Supply Vapes Illegally
Australia TGA Warns Delivery Platforms: Don’t Promote or Supply Vapes Illegally
The Therapeutic Goods Administration (TGA) warned online delivery platforms not to breach Australian vape laws and said it worked with two major companies to remove non-compliant material. Under the Therapeutic Goods Act 1989, advertising vapes to the public is banned and sales are pharmacy-only; tobacconists and convenience stores cannot supply vapes. TGA will continue enforcement, with severe penalties for breaches.
Oct.30 by 2FIRSTS.ai
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire and IKE Tech Welcome FDA Enforcement Boost, Highlight Need for Tech-Based Controls
Ispire Technology and IKE Tech issued statements after the U.S. FDA received Congressional funding and directives to strengthen enforcement against illicit vaping products. The companies emphasized updated guidance, multi-agency coordination and the role of blockchain and age-verification technologies in preventing illegal imports and protecting youth.
Nov.20
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Canada’s STLTH has teamed up with GEEK BAR to launch the disposable “STLTH X GEEK BAR 80K,” featuring 30 ml of e-liquid and up to 80,000 puffs. The device is now available across multiple retail channels in Canada, priced around C$44.99–48.99.
Oct.30 by 2FIRSTS.ai
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Group said its controlling shareholder, Jinjia Venture, will have part of its holdings auctioned by the Shenzhen Nanshan Court, involving 43.4 million shares. Earlier, the Shenzhen Intermediate Court announced another auction of 37.27 million shares. Together they represent 5.56% of total equity. Jinjia said the auctions will not affect company control.
Oct.23 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai